Esperion Therapeutics, Inc.
ESPR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $92 | $86 | $115 | $145 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $119 | $108 | $81 | $80 |
| Inventory | $142 | $114 | $99 | $94 |
| Other Curr. Assets | $7 | $34 | $24 | $19 |
| Total Curr. Assets | $360 | $343 | $319 | $338 |
| Property Plant & Equip (Net) | $4 | $4 | $5 | $6 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $4 | $4 | $5 | $6 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $364 | $347 | $324 | $344 |
| Liabilities | – | – | – | – |
| Payables | $78 | $75 | $72 | $52 |
| Short-Term Debt | $152 | $124 | $57 | $57 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $5 | $9 |
| Other Curr. Liab. | $129 | $100 | $137 | $129 |
| Total Curr. Liab. | $359 | $299 | $271 | $246 |
| LT Debt | $449 | $474 | $240 | $240 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $7 | $7 | $239 | $246 |
| Total NC Liab. | $456 | $482 | $479 | $486 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $4 | $5 | $5 |
| Total Liabilities | $815 | $781 | $750 | $733 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,686 | -$1,654 | -$1,641 | -$1,601 |
| AOCI | -$0 | -$0 | $0 | $0 |
| Other Equity | $1,234 | $1,221 | $1,215 | $1,212 |
| Total Equity | -$451 | -$434 | -$426 | -$389 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $364 | $347 | $324 | $344 |
| Net Debt | $509 | $512 | $183 | $153 |